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Background: The Norwegian Mother and Child Cohort Study (MoBa) is a nation-wide population-based pregnancy
cohort initiated in 1999, comprising more than 108.000 pregnancies recruited between 1999 and 2008. In this study
we evaluated the feasibility of integrating RNA analyses into existing MoBa protocols. We compared two different
blood RNA collection tube systems – the PAXgene™ Blood RNA system and the Tempus™ Blood RNA system - and
assessed the effects of suboptimal blood volumes in collection tubes and of transportation of blood samples by
standard mail. Endpoints to characterize the samples were RNA quality and yield, and the RNA transcript stability of
selected genes.
Findings: High-quality RNA could be extracted from blood samples stabilized with both PAXgene and Tempus
tubes. The RNA yields obtained from the blood samples collected in Tempus tubes were consistently higher than
from PAXgene tubes. Higher RNA yields were obtained from cord blood (3 – 4 times) compared to adult blood
with both types of tubes. Transportation of samples by standard mail had moderate effects on RNA quality and
RNA transcript stability; the overall RNA quality of the transported samples was high. Some unexplained changes in
gene expression were noted, which seemed to correlate with suboptimal blood volumes collected in the tubes.
Temperature variations during transportation may also be of some importance.
Conclusions: Our results strongly suggest that special collection tubes are necessary for RNA stabilization and they
should be used for establishing new biobanks. We also show that the 50,000 samples collected in the MoBa
biobank provide RNA of high quality and in sufficient amounts to allow gene expression analyses for studying the
association of disease with altered patterns of gene expression.
Keywords: Tempus tubes, PAXgene tubes, Cord blood, Quality control, RNA stabilization, Biobank, Blood RNA, Gene
expressionFindings
Background
The Norwegian Mother and Child Cohort Study (MoBa)
is a nation-wide population-based pregnancy cohort
initiated in 1999 [1,2]. The MoBa holds more than
108,000 pregnancies recruited between 1999 and 2008;
the last child to be included was born in June 2009. In
addition to detailed questionnaire data, biological mate-
rials from the mother, the father and the child (umbilical
cord blood) in the form of whole blood and plasma, have
been collected and are stored in a biobank at the* Correspondence: nur.duale@fhi.no
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reproduction in any medium, provided the orNorwegian Institute for Public Health (NIPH) together
with extracted DNA, for future use [2]. The DNA is rou-
tinely extracted from the blood samples from each par-
ticipant and frozen in aliquots. In 2005 funds were
obtained from the US National Institutes of Health
through the Autism Birth Cohort to initiate RNA collec-
tion for the purpose of gene expression analyses. The
challenge in implementing RNA collection was to devise
a new protocol that would be feasible in maternity units
and during transportation - and at the same time the
existing routines and logistics of the cohort should be
adhered to as closely as possible. There are several
reports on the ex vivo instability of RNA transcripts
[3-5], and it is therefore very important to stabilize blood
RNA during sample collection, transport, and storagetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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results.
The overall goal of this study was to establish a prac-
tical protocol for sampling, handling, transportation and
storage of adult and cord blood RNA. On this back-
ground, we systematically compared the RNA quality,
quantity, and the RNA transcript stability of two com-
mercially available RNA stabilizing technologies PAX-
gene™ Blood RNA system (PreAnalytiX, QIAGEN/BD,
Hombrechtikon, Switzerland), and Tempus™ Blood RNA
system (Applied Biosystems, Foster City, CA). We then
investigated the effects of transportation and blood
volumes on the RNA transcript stability of six selected
genes (CDKN1A, FOS, IL8, MYC, IL1B, and TP53) using
quantitative real-time PCR (RT-qPCR). These genes
were selected based on literature search [7,8].
Results and discussion
In MoBa, the combination of biological specimens and
questionnaire data on lifestyle and exposures provide
unique possibilities to study the effects of many factors
of relevance for pregnancy outcomes and health [1].
Blood-based large biobanks such as MoBa, and multi-
center studies, increasingly incorporate gene expression
profiling studies in order to get insight into the bio-
logical mechanisms triggered by gene-environment
interactions and disease. However, collection, transporta-
tion, processing and storage of blood samples may repre-
sent logistical and technical challenges [9,10]. Therefore,Adult blood
(Venous blood from healthy 
adult donors)  
1.RNA yield, purity and integrity by NanoD
2.RNA transcript stability by RT-qPCR
PAXgene™ tubes (n=20)
Tempus™ tubes (n=20)
Suboptimal blood volume QC: 
Adult blood from one healthy donor was collected in Tempus™ tubes (n = 18)
Blood volume (ml) collected in Tempus™ tubes: 3.0, 2.5, 2.0, 1.5, 1.0 and 0.5 
3 parallels for each volume.
Transportation QC: Tempus (n=20) tubes
Adult blood from one healthy donor was collected in Tempus™ tubes (n = 20).
Samples were divided randomly into five groups: 4 groups were sent by 
standard mail to four different hospitals in Norway: Kirkenes, Bergen, 
Kristiansand, Bærumand the fifth group was kept at Oslo (NIPH, lab).  
Temperature was monitored during transportation.
Samples were frozen upon arrival at NIPH.
RNA stabilizing technologies comparison: 
Adult blood (n=40) tubes from one healthy donor 
Stored 0, 2, 5, 7 days at RT (~22 °C)  





Figure 1 Flow chart: experimental design.establishment of robust and standardized protocols is a
prerequisite in order to reduce the impact which preanaly-
tical sample handling may exert on RNA quality and sta-
bility. This is particularly important when collecting blood
samples for large-scale biobanks, where the associated
costs are very high.
In this study, we investigated important input factors
for large-scale collection of blood from adults and chil-
dren (umbilical cord blood). Although high-quality RNA
can be prepared using fresh blood that is processed im-
mediately, this option is hardly realistic when sampling
for a large-scale biobank.
Comparison of two RNA stabilizing systems, PAXgene and
Tempus
Two commercially available blood RNA stabilizing sys-
tems, the PAXgene blood RNA system and Tempus
blood RNA system, were available as evacuated tubes
containing RNA stabilizing reagents, and both PAXgene
[7,11,12] and Tempus [13] blood RNA systems have
been shown to provide efficient stabilization of the
blood RNA for several days at room temperature. In this
study, the two systems were systematically evaluated
regarding their performance to stabilize blood RNA; i.e.
preserving the RNA quality, yield, and the RNA tran-
script stability of four selected genes (CDKN1A, IL8,
MYC, and TP53). The study design for blood collection
is outlined in Figure 1. The RNA qualities and yields for
samples collected directly into PAXgene or TempusCord blood
(Umbilical cord of newborns whose mothers 
have given their informed consent to participate 
in the Mother and Child (MoBa) Study)
rop™ and by Agilent Bioanalyzer 
NA stabilizing technologies comparison:
Cord blood (n = 15) tubes from 8 different donors, 
transported from one hospital to NIPH within 1 day.
Samples were frozen upon arrival at NIPH at -20 °C 
overnight and then stored at -80 °C until extraction
uboptimal blood volume QC:
Cord blood from one donor was collected in Tempus™ tubes (n = 10). 
Blood volume (ml) collected in Tempus™ tubes: 3.3, 3.0, 2.0, 1.0, 0.5 ml.  
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D) Cord blood samples collected in Tempus or PAXgene  tubes 
PAXgene (n=8) Tempus (n=7)
Figure 2 Comparison of PAXgene and Tempus tubes. Blood
(adult or cord blood) was collected either in the PAXgene tubes or in
the Tempus tubes, and stored at room temperature for the indicated
number of days, followed by total RNA isolation. Five tubes were used
at each time point (n = 5). A) The RNA yield from the cord blood and
the adult blood samples collected either in the PAXgene tubes or in
the Tempus tubes. Each bar represents the average RNA yield per
tube ± SE. B) Relative transcript levels of four genes from adult blood
samples collected in the PAXgene tubes and stored for up to seven
days at room temperature; C) Relative transcript levels of four genes
from adult blood samples collected in the Tempus tubes and stored
for up to seven days at room temperature. The 0 day samples were
used as reference samples (calibrators); hence all other samples were
compared against the reference samples. Each bar represents the
average log2-transformed fold change values and the error bar
indicates ± SE. The dashed lines indicate ± 2 – fold change. The fold
change detected for the genes were within ± 2 – fold. D) The
normalized expression values of four genes from cord blood samples
collected in the PAXgene tubes (n = 8) and in the Tempus tubes
(n = 7). Each bar represents the normalized expression values
[2-ΔCq (sample); where the ΔCq (sample) ± Cq (gene) – Cq (internal
control)] and the error bar indicates ± SE.
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total RNA yields for adult and cord blood samples col-
lected in the PAXgene tubes were 2.1 ± 0.2 μg and
7.8 ± 1.7 μg per ml blood, respectively, while the average
total RNA yields for samples collected in the Tempus tu-
bes were 5.3 ± 0.2 μg per ml blood for adult blood and
21.6± 3.8 μg per ml blood for cord blood (Figure 2A). The
difference in yield per ml blood between the two types of
collection tubes was significant (p < 0.05). The obtained
RNA yields for blood samples collected in the Tempus
tubes were consistently higher than for samples collected
in the PAXgene tubes (Figure 2A). Higher RNA yields from
the Tempus tubes compared with PAXgene tubes have
been previously reported [14,15]. The RNA yield obtained
from cord blood samples was 3–4 times higher than from
adult blood using both types of tubes (Figure 2A).
The integrity and purity of RNA can be used to evalu-
ate the quality of sample handling and processing. A
RIN-value higher than five is considered as indicating
good quality RNA whereas RIN-values above eight are
considered ideal for downstream applications [4,5].
When we investigated the RNA quality, we observed
similar and comparable average OD 260/280 ratios and
average RIN values for all adult and cord blood samples
collected in Tempus and PAXgene tubes (p > 0.05), but
the average OD 260/230 ratio for the samples collected
in the PAXgene tubes was lower (p < 0.05) than for sam-
ples collected in Tempus tubes (Table 1). It has previ-
ously been reported that OD 260/230 ratios are higher
for Tempus tubes compared with PAXgene tubes [15].
The observed differences in the average OD 260/230
ratio between the two systems may be due to the
PAXgene elution buffer which may contain high salt
contents. Storage of PAXgene and Tempus samples at
Table 1 Comparison of blood samples collected in











0 8.0 ± 0.3 2.12 ± 0.02 1.56 ± 0.31 5
2 8.0 ± 0.3 2.10 ± 0.03 1.56 ± 0.62 5
5 8.2 ± 0.3 2.12 ± 0.02 1.37 ± 0.73 5
7 8.2 ± 0.3 2.09 ± 0.03 1.42 ± 0.70 5
Average 8.10 ± 0.3 2.11 ± 0.02 1.48 ± 0.61* 20
Tempus tubes
0 8.0 ± 0.3 2.12 ± 0.07 2.01 ± 0.14 5
2 8.2 ± 0.3 2.12 ± 0.07 2.01 ± 0.14 5
5 8.0 ± 0.3 2.14 ± 0.08 2.09 ± 0.08 5
7 8.2 ± 0.3 2.11 ± 0.04 2.08 ± 0.06 5






RIN value 8.1 ± 0.2 8.0 ± 0.2
OD 260/280
ratio
2.1 ± 0.1 2.0 ± 0.3
OD 260/230
ratio
1.6 ± 0.5* 2.0 ± 0.8
Notes. * RNA from PAXgene tube-collected samples have significantly lower
OD 260/230 ratio compared to RNA from Tempus tube-collected samples,
p < 0.05. The cord blood samples were transported to NIPH (lab) within one
day. n = number of tubes.
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RNA quality, although a slight decrease in RNA yield
(p < 0.05) was observed for adult samples collected in the
PAXgene tubes at seven days of storage (Figure 2A). The
RNAs isolated from both PAXgene and Tempus had aver-
age RIN-values of approximately eight, and average OD
260/A280 ratios were above 1.8 (Table 1). Based on these
data, high-quality RNA could be extracted from blood
samples stabilized with both PAXgene and the Tempus
system.
The RNA transcript stability and potential alteration of
the transcript level for four genes (CDKN1A, IL8, MYC,
and TP53) were investigated by RT-qPCR (Figure 2B-D).
Storage of both PAXgene and Tempus tubes at room
temperature for up to seven days had some effect on RNA
transcript stability; there were clear storage related changes
in the transcript levels. For adult blood samples collected
both in PAXgene and Tempus tubes, storage for up to
seven days at room temperature had effects on the relative
transcript levels for the four genes when compared to the
day 0 samples (Figure 2B and C). Storage effects were more
pronounced in samples collected in the PAXgene compared
to the Tempus tubes. However, the observed transcript
level changes were within ±2–fold for both types of tubes(Figure 2B and C). The non-normalized raw Cq-values for
the four genes also illustrate similar trends (Additional file
1A and B). The differences in the Cq-values between stored
and day 0 samples for each gene were very small. For cord
blood samples, the average transcript levels for the four
genes were comparable between the Tempus and the
PAXgene tube samples, and the difference between the two
systems (Figure 2D and Additional file 1C) was not signifi-
cant (p> 0.05). Storage for up to 7 days exceeds the
maximum period (3–5 days) as recommended by both
manufacturers. The recommended storage time may be
too strict, and a more flexible protocol – also giving RNA
of acceptable quality - can more conveniently be imple-
mented in multi-center studies.
Given the results of this initial investigation where
samples collected in the Tempus tubes gave higher RNA
yields with comparable quality when compared to
PAXgene tubes, we selected the Tempus Blood RNA
system for MoBa and began collecting cord blood in
Tempus tubes in June 2005. Since then, approximately
50,000 samples have been collected and stored at −80°C.
Transportation QC: The effect of transportation on RNA
quality and transcript stability
The maternity units where sample collection took place
are located all over Norway, and from a few hours up to
several days may be required before the blood samples
arrive for processing at the NIPH biobank. The distance
between blood collection location and the biobank, and
the associated differences in duration and temperature
fluctuations during transportation, may affect the quality
of the obtained RNA and subsequently the gene expres-
sion data. We investigated the effect of transportation
on RNA quality and transcript stability of six genes
(CDKN1A, FOS, IL8, MYC, IL1B, and TP53) which have
been used in earlier studies [7,8]. Whole venous blood
from one healthy donor (Figure 1) was collected by ven-
ous puncture into 20 Tempus tubes. The tubes were
divided randomly into five groups, of which four were
sent by standard mail to four maternity units in Norway
whereas the fifth was kept at room temperature (24.4 ±
1.9°C) in the NIPH laboratory in Oslo. Samples were
returned from the maternity units to NIPH and kept
there at room temperature until all four sets had arrived;
they were then frozen at −20°C at the same time fol-
lowed by transfer to −80°C 24 hours later. The tem-
perature logs showed values during transportation ranging
from 3.4°C to 27.1°C; none of the samples were - or had
been - frozen (Additional file 2A). Samples sent to Kristian-
sand had the highest mean temperature (20.28±5.58°C),
while those to Bærum had the lowest mean temperature
(16.96±8.55°C). The mean temperature differences be-
tween the transported samples and samples kept at NIPH
are presented in Additional file 2A. Samples sent to Bærum
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tive to the samples kept at NIPH. RNA was extracted from
all samples and analyzed for quality, and RT-qPCR was
carried out to measure the relative transcript levels for
the six selected genes. Figure 3A shows that trans-
portation of samples by standard mail apparently affected
RNA quality, especially the RNA integrity expressed as
RIN value. There was a statistically significant location-
dependent reduction in the average RIN value (p< 0.05);
samples kept at NIPH had the highest RIN values; the
lowest were from the Kirkenes and Bergen samples. The
temperature recordings were divided into 12-hour inter-
vals and averaged (Additional file 2A). Compared to the
other samples, those from Bærum had much lower
temperature (≤ 6°C) for two 12-hour time intervals. This







































B) The effects of transportation on relative transcript levels
CDKN1A FOS IL8 MYC IL1B TP53
Figure 3 The effects of transportation on RNA, quantity, quality
and transcript stability. Adult blood from one healthy donor was
collected in Tempus™ tubes (n = 20). Samples were divided
randomly into five groups (n = 4 tubes per group): four groups were
sent by standard mail to four different hospitals in Norway, and the
fifth group was kept at NIPH (Oslo/lab). Temperature was monitored
during transportation. A) The effects of transportation on RNA
quality and yield; B) The effects of transportation on RNA transcript
levels of six genes. Samples kept at NIPH were used as reference
samples; hence all other samples were compared against the
reference samples. Each bar represents the average
log2-transformed fold change values and the error bar
indicates ± SE. The dashed lines indicate ± 2 – fold change.particular samples (Figure 3A and Additional file 2B). In
any case, the average RIN value for each group was greater
than six, which is considered acceptable for many RNA
assays.
Figure 3B shows the relative transcript levels for the
six genes. Transportation of the samples apparently
affected the relative transcription levels of the genes.
Samples sent to Kirkenes or Kristiansand showed the
highest changes compared to the samples kept at NIPH
(control samples) (Figure 3B). However, the observed
transcript level changes were again within ± 2–fold. The
non-normalized raw Cq-values for the six genes and the
average raw Cq-values ± SD for each gene are presented
in Additional file 2D. Differences in the Cq-values be-
tween transported samples and samples kept at NIPH
for each gene were small. A significant finding is that
higher RNA yields were obtained from transported sam-
ples compared to samples kept at NIPH (Figure 3A and
Additional file 2C); the reason for this is unclear. Sam-
ples can be shaken during transportation due to mech-
anical movements and vibrations, and temperature
fluctuations occur (Additional file 2C), which may affect
the RNA extraction efficiency.
Overall, transportation of the samples by standard
mail had some effects on RNA yield, quality and RNA
transcript stability. Temperature fluctuations, mechan-
ical movements or vibrations during the transportation
of samples may have contributed to the differences
(Figure 3 and Additional file 2). However, the observed
differences between transported samples and samples
kept at NIPH were minor, and the obtained RNA qual-
ity from transported samples was considered acceptable
for many RNA assays. Our results therefore suggest
that blood samples collected in Tempus tubes can be
sent by standard mail, under the conditions employed
in this study.
Suboptimal blood volume QC: The effect of suboptimal
blood volume on RNA quality and transcript stability
Regular sample collections for the MoBa biobank were
carried out in busy maternity units. A considerable por-
tion of the samples collected contains blood volumes less
than the optimal volume recommended by the manufac-
turer (Figure 4A); this is a common problem when collec-
ting cord blood for research purposes. Figure 4A shows
cord blood collected in Tempus tubes from different ma-
ternity units during a period of one year (n= 10835). We
observed that~ 20% of the tubes contained less than 2 ml
blood. We investigated whether the recommended blood–
to–RNA stabilizing reagent ratio was critical for blood
RNA quality and RNA transcript stability, and observed a
significant (p < 0.05) blood volume-dependent reduction
in RNA yield, RIN value, and OD 260/280 and OD 260/
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Figure 4 The effect of suboptimal blood volume collected in
the Tempus tubes on RNA quality and transcript stability.
A) Cord blood collected in Tempus tubes from maternity units in a
period of one year (n = 10 853). B) The effects of suboptimal volume
of adult blood collected in the Tempus tubes on relative transcript
level for six genes. Adult blood from one healthy donor was
collected in Tempus tubes (n = 18). The following blood volumes
(3.0, 2.5, 2.0, 1.5, 1.0 and 0.5 ml) were collected in the Tempus tubes
(n = 3; three parallels tubes for each blood volume). C) The effects of
suboptimal volume of cord blood collected in the Tempus tubes on
relative transcript level for six genes. Cord blood from one donor
was collected in Tempus tubes (n = 10). The following blood
volumes (3.3, 3.0, 2.0, 1.0, and 0.5 ml) were collected in the Tempus
tubes (n = 2; two parallels tubes for each blood volume). Samples
with 3 ml blood per tube were used as reference samples; hence all
other samples were compared against the reference samples. Each
bar represents the average log2-transformed fold change values and
the error bar indicates = SE. Since some of the samples had low RNA
quality, selecting stably expressed reference genes for normalization
was a challenge. We therefore used the average Cq value for each
gene to normalize the samples: ΔCq (sample) = Cq (gene) – Cq
(average); these values where converted into linear scale, 2-ΔCq. Fold
changes were calculated by dividing ΔCq value of the sample by
the ΔCq value of the reference sample.
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2 ml. This was true for adult blood, but suboptimal blood
volumes were not critical when collecting cord blood
(Table 2B).
The relative transcript levels for the six genes are
shown in Figure 4B and C. We observed blood–volume
dependent reduction in the relative transcript levels for
the six genes compared with samples with 3 ml blood
volume (Figure 4B and C). Samples with volumes less
than 1.5 ml for adult blood and less than 1.0 ml for cord
blood showed the highest changes in the relative tran-
script levels for the six genes, compared with the optimal
3 ml samples (Figure 4B and C). The non-normalized
raw Cq-values for adult and cord blood samples show asimilar trend (Additional file 3A and B). Furthermore,
overfilling the Tempus tubes with cord-blood, i.e. more
than 3 ml blood per tube, seems to affect the apparent
RNA transcript stability, suggesting that the blood–to–
RNA stabilizing reagent ratio limit was exceeded
(Figure 4C). Our results indicate that the blood–to–RNA
stabilizing reagent ratio is very important for blood RNA
quality and transcript stability for adult blood samples,
whereas the blood volume is less critical for cord blood
samples. Hence, collection of 3 ml of blood per Tempus
tube will always be the highly recommended optimal
blood volume, but this volume is not always possible
when blood collection is carried out in a busy maternity
unit. For adult blood samples it is advisable to collect
3 ml blood per Tempus, whereas for cord blood samples,
minor deviations from the optimal volume per tube may
be acceptable.
Conclusions
Our results indicate that blood samples in a large bio-
bank such as MoBa can be used to obtain high-quality
RNA suitable for gene expression analysis, provided that
special collection tubes are used. The quality of the RNA
isolated from such tubes is crucial for successful tran-
script profiling analyses. Transportation of samples by
standard mail apparently affected the RNA quality and
RNA transcript stability, but the changes were moderate
and the overall RNA quality of the transported samples
was good. Some unexplained changes in gene expression
changes seem to be associated with suboptimal blood
volumes collected in the tubes. Overall, we demonstrate
that satisfactory amounts of high-quality RNA can be
Table 2 The effect of blood volume in the Tempus tubes on RNA quality
Blood volume (ml) Yield total RNA (ug) RNA Integrity Number (RIN) OD260/280 ratio OD2602/230 ratio
A) Adult blood samples (n = 3)*
3.0 7.90 ± 1.50 8.20 ± 0.06 2.19 ± 0.02 2.10 ± 0.23
2.5 3.38 ± 0.90 8.13 ± 0.27 2.24 ± 0.05 0.91 ± 0.46
2.0 2.94 ± 0.91 8.40 ± 0.08 2.12 ± 0.08 1.05 ± 0.53
1.5 1.38 ± 0.59 3.53 ± 2.53 2.51 ± 0.08 0.64 ± 0.32
1.0 0.55 ± 0.50 1.13 ± 0.13 1.19 ± 0.44 0.38 ± 0.38
0.5 0.07 ± 0.03 1.00 ± 0.00 0.77 ± 0.39 0.05 ± 0.05
B) Cord blood samples (n = 2)
3.3 79.65 ± 4.76 7.15 ± 0.78 2.15 ± 0.00 2.12 ± 0.00
3.0 74.60 ± 1.23 7.50 ± 0.65 2.17 ± 0.00 2.15 ± 0.01
2.0 44.42 ± 1.91 9.10 ± 0.00 2.18 ± 0.01 2.09 ± 0.01
1.0 33.92 ± 3.13 9.45 ± 0.04 1.98 ± 0.01 1.61 ± 0.02
0.5 4.29 ± 0.11 1.03 ± 0.03 1.25 ± 0.03 0.53 ± 0.01
Notes. *There are significant blood volume dependent reductions in the RNA yields and in the RNA qualities (RIN, OD 260/280 and OD 260/230 ratio), p < 0.05.
n = number of tubes.
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bank. This is good news for future projects studying asso-
ciation of disease with altered patterns of gene expression.Methods
Blood collection and study design
Whole blood was collected at a maternity unit in Oslo
from the umbilical cord of newborns whose mothers
had given their informed consent to participate in the
MoBa project. Venous blood samples were obtained via
phlebotomy from healthy adult donors among the NIPH
staff after informed consent. The study design for blood
collection is outlined in Figure 1. Samples were collected
either into Tempus™ Blood RNA Tubes (space for 3 ml
blood) (Applied Biosystems, Foster City, CA) or PAX-
gene Blood RNA Tubes (space for 2.5 ml blood) (PreA-
nalytiX, Qiagen, Germany). Samples collected at NIPH
(Oslo) were stored for 2 h at room temperature, then at
– 20°C for 24 h and finally transferred to – 80°C for
long-term storage. Samples shipped by standard mail
were then stored at – 20°C for 24 h after arrival at
NIPH, and then transferred to – 80°C for long term
storage. All samples were handled as recommended by
the manufacturers prior to processing.
The adult blood samples collected to study the effects
of transportation were shipped to 4 different locations
in Norway, with instructions to treat the tubes the same
way (temperature, storage) as tubes collected in the
local maternity unit, and then to return the tubes to
NIPH as it would be normally done with the collected
tubes. The four sets were shipped by standard mail to
the maternity units in Bærum (~15 km from Oslo),
Kristiansand (~ 320 km), Bergen (~ 520 km) and Kir-
kenes (~ 2000 km). A fifth set of samples was let at roomtemperature at NIPH (Oslo/lab). The tubes were sent to
the hospitals and then returned by the local staff to
NIPH, to comprise a worst-case scenario of double the
ordinary mail transportation time. Upon arrival at NIPH
samples were kept at RT until the last sample arrived and
then they were all frozen at the same time. Temperature
was monitored during the transportation using small
sensors with memory (Tinytag Talk2, Precision Technic
Nordic, Rødovre, Denmark). The Regional Ethics Com-
mittee and the Data Inspectorate approved the MoBa
study, and participants gave their informed consent.RNA extraction
Total RNA from whole blood collected in PAXgene
tubes was extracted according to the manufacturer’s ins-
tructions and included DNase I treatment (PreAnalytiX,
QIAGEN/BD, Hombrechtikon, Switzerland). Total RNA
from blood collected in Tempus tubes was extracted using
the Tempus™ 6-Port RNA Isolation Kit Protocol on an
ABI PRISMW TM 6100 Nucleic Acid PrepStation accor-
ding to the manufacturer’s instructions and included DNase
I treatment and addition of 1X PBS bringing the total vo-
lume to 12 ml prior to processing (Applied Biosystems,
Foster City, CA).
An aliquot of 5 μl of each extracted total RNA was
used for RNA quality control assessments, while the
remaining RNA sample was stored at – 80°C until use.RNA QC
The concentration of extracted total RNA was measured
using NanoDrop ND-1000 spectrophotometer (Fisher
Scientific, Norway). RNA purity was estimated by exam-
ining the OD 260/280 and the OD 260/230 ratios. The
RNA integrity was assessed by Agilent 2100 Bioanalyzer
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and Eukaryote total RNA Nano assay according to the
manufacturer’s instructions (Agilent Technologies, Palo
Alto, CA). The RNA integrity numbers (RIN) were cal-
culated using the Agilent 2100 Expert Software (RIN= 1;
low RNA quality to RIN= 10; highest RNA quality).
Quantitative real-time PCR measurement
Total RNA (500 ng) from samples was used as template
for the synthesis of cDNA using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA) according to manufacturer’s protocol. The
amplification reactions were carried out in an Eppendorf
MasterCycler (Eppendorf, Hamburg, Germany) with the
following steps: 10 minutes at 25°C, 2 hours at 37°C and fi-
nally, 5 minutes at 85°C. The quality of the cDNA was
assessed by the NanoDrop ND-1000 spectrophotometer
(Fisher Scientific), and the cDNA was stored at - 20°C until
use.
Quantitative real-time PCR (qPCR) was performed in
96-well PCR plates using a 7500Fast Real-Time PCR Sys-
tem (Applied Biosystems, Foster City, CA). The cDNA
samples were diluted 10-fold and gene-specific transcrip-
tion levels were determined in a 20 μl reaction volume in
triplicates using TaqManWFast PCR Universal PCR Mas-
ter mix following the manufacturer’s protocol. Commer-
cially available primers and probe assays were from
Applied Biosystems: IL1B (PN: Hs00174097_m1), IL8
(PN: Hs00174103_m1), FOS (PN: Hs00170630_m1), MYC
(PN: Hs00153408_m1), TP53 (PN: Hs00153340_m1), and
CDKN1A (PN: Hs00355782_m1), and 18S rRNA (PN:
Hs99999901_s1). The PCR cycling program included an
enzyme activation step at 95°C for 20 seconds, and then
40 cycles of annealing and extension steps at 95°C for
3 seconds and 60°C for 30 seconds, respectively.
Data analysis
The quantification cycle (Cq; standard name for Ct and
Cp [16]) values were recorded with SDS v1.3 software
(Applied Biosystems, Foster City, CA); the Cq value is
the fractional cycle number at which the fluorescence
exceeds a fixed threshold. The raw Cq-values were then
exported into Excel- files and analyzed by the compara-
tive Cq – method [17,18] using 18S rRNA as internal
control. Targets with Cq-values > 35 were considered be-
yond the limit of detection (LOD) and all Cq-values
above 35 were coded as missing values. For downstream
analysis missing values were replaced by Cq (LOD) + 1
(i.e., 35 + 1: Cq= 36). Target genes were normalized to
18S rRNA internal controls, [this is given by ΔCq; where
ΔCq (sample) =Cq (target gene) – Cq (internal controls)].
The ΔΔCq values were generated by subtracting the ΔCq-
value for the reference samples (calibrators) from the
ΔCq-value for the samples [ΔΔCq=ΔCq (sample) – ΔCq(calibrator); fold change= 2-ΔΔCq]. A reference sample was
determined within each study, and for samples without an
obvious reference sample (calibrator), the linear scale of
ΔCq (sample); 2-ΔCq was used [17,18]. The fold change
values were then log2-transformed in order to make the
values symmetrical around zero. The 18S rRNA stability
was evaluated and results are presented in Additional file 4.
These four genes: CDKN1A, IL8, MYC, and TP53 were
analyzed when the two RNA stabilization systems (PAX-
gene and Tempus) were compared, and then two more
genes (FOS and ILB) were added, i.e. six genes were ana-
lyzed in the remaining study.
Statistical analysis
Statistical analysis of RNA yield, purity, integrity and
ΔCq - values was carried out by one-way analysis of
variance (ANOVA), followed by post hoc Dunnett’s tests
to allow for multiple comparisons or by non-parametric
Kruskal-Wallis test. Normal distribution and equality of
variances was evaluated using the Shapiro-Wilk test and
the Levene's test of homogeneity of variance. Two-
sample t-test was used to compare cord blood samples
collected in the PAXgene vs the Tempus tubes. The data
are presented as means ± SE. Statistical analyses were
performed using SPSS v17 software (SPSS, Inc., Chicago,
IL), and p < 0.05 was accepted as statistically significant.
Additional files
Additional file 1: The non-normalized raw Cq-values. A) The
non-normalized raw Cq-values for adult blood samples collected in the
PAXgene tubes; B) The non-normalized raw Cq-values for adult blood
samples collected in the Tempus tubes; C) The non-normalized raw
Cq-values for cord blood samples collected in the PAXgene and in the
Tempus tubes. Each bar represents the average Cq-values and the error
bar indicates ± SE.
Additional file 2: Temperature recordings for transported samples
vs RIN, RNA yield and Raw Cq-value. Temperatures were monitored
during the transportation of the samples to four different locations
(hospitals) in Norway. The four samples were sent by standard mail at
February 21th and all samples returned to NIPH at February 24th.
Transportation time for samples sent to Bærum, Kristiansand and Bergen
was ~ 48 hours, while it took ~ 74 hours for Kirkenes samples to return to
NIPH. The temperature variations ranged from 3.4°C to 27.1°C, and none
of the samples were frozen during the transportation. A) Temperature
recordings for samples sent to the four locations and samples kept at
NIPH; B) RIN values vs. average temperature (°C) of the samples; C) RNA
yields vs. average temperature (°C) of the samples; D) The non-
normalized raw Cq-values vs. average temperature (°C) of the samples.
Each bar represents the average Cq-values and the error bar
indicates ± SE for the raw Cq-values or ± SD for average temperature (°C)
of the samples.
Additional file 3: The non-normalized raw Cq-values for suboptimal
blood volume QC. A) Evaluation of the non-normalized raw Cq-values
for suboptimal blood volume QC from adult blood samples; and B)
Evaluation of the non-normalized raw Cq-values for suboptimal blood
volume QC from cord blood samples. Each bar represents the average
Cq-values and the error bar indicates ± SE.
Additional file 4: The evaluation of 18S rRNA stability.
A) Comparison of PAXgene tube-collected samples against the Tempus
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http://www.biomedcentral.com/1756-0500/5/510tube-collected samples: The Cq – values for 18S rRNA were relatively
stable following the storage of the tubes for up to seven days at room
temperature for both tubes; B) Evaluation of 18S rRNA stability for
transportation QC samples: The Cq – values for 18S rRNA were relatively
stable following the transportation; C) Suboptimal blood volume in the
Tempus tubes on 18S rRNA expression stability for adult blood samples:
Suboptimal blood volume collected in the tube has a significant effects
on 18S rRNA expression stability; and D) Suboptimal blood volume in the
Tempus tubes on 18S rRNA expression stability for cord blood samples:
Suboptimal blood volume collected in the tube has some effects on 18S
rRNA expression stability. Each bar represents the average Cq-values and
the error bar indicates ± SE.
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